FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fenofibrate filed by Lupin Pharmaceuticals, Inc. under NDA 021695. The approval updates the fenofibrate product via …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)